Annual CFI
N/A
01 December 2023
Summary:
Revelation Biosciences annual cash flow from investing activities is not available.REVB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$17.70 K
-$17.70 K-100.00%
01 September 2024
Summary:
Revelation Biosciences quarterly cash flow from investing activities is currently -$17.70 thousand, with the most recent change of -$17.70 thousand (-100.00%) on 01 September 2024. REVB quarterly CFI is now -209.26% below its all-time high of $16.20 thousand, reached on 31 December 2021.REVB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$36.90 K
-$17.70 K-92.19%
01 September 2024
Summary:
Revelation Biosciences TTM cash flow from investing activities is currently -$36.90 thousand, with the most recent change of -$17.70 thousand (-92.19%) on 01 September 2024.REVB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REVB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | -100.0% | +75.1% |
| 5 y5 years | - | - | - |
REVB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -209.3% | +7.8% | +75.1% | |||
| 5 y | 5 years | -209.3% | +82.1% | +75.1% | |||
| alltime | all time | -209.3% | +82.1% | <-9999.0% | +75.1% |
Revelation Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.70 K(<-9900.0%) | -$36.90 K(+92.2%) |
| June 2024 | - | $0.00(-100.0%) | -$19.20 K(0.0%) |
| Mar 2024 | - | -$19.20 K(<-9900.0%) | -$19.20 K(<-9900.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2021 | -$132.00 K | $16.20 K(>+9900.0%) | -$131.90 K(-10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $0.00(-100.0%) | -$148.10 K(0.0%) |
| June 2021 | - | -$49.00 K(-50.6%) | -$148.10 K(+49.4%) |
| Mar 2021 | - | -$99.10 K | -$99.10 K |
| Dec 2019 | -$368.60 M(+25.0%) | - | - |
| Dec 2018 | -$294.85 M(+17.2%) | - | - |
| Dec 2017 | -$251.59 M(+27.9%) | - | - |
| Dec 2016 | -$196.67 M(+3.8%) | - | - |
| Dec 2015 | -$189.56 M | - | - |
FAQ
- What is the all time high annual CFI for Revelation Biosciences?
- What is Revelation Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Revelation Biosciences?
- What is Revelation Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Revelation Biosciences?
What is the all time high annual CFI for Revelation Biosciences?
Revelation Biosciences all-time high annual cash flow from investing activities is -$132.00 K
What is Revelation Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of REVB is -$17.70 K
What is the all time high quarterly CFI for Revelation Biosciences?
Revelation Biosciences all-time high quarterly cash flow from investing activities is $16.20 K
What is Revelation Biosciences TTM cash flow from investing activities?
The current TTM CFI of REVB is -$36.90 K
What is the all time high TTM CFI for Revelation Biosciences?
Revelation Biosciences all-time high TTM cash flow from investing activities is $0.00